SHANGHAI LABWAY CLINICAL LABORATORY CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.21 CNY | +1.11% |
|
+1.73% | -38.22% |
| 30/05 | Labway Clinical Laboratory Names Chief Financial Officer | MT |
| 26/04 | Shanghai Labway Clinical Laboratory Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bearish |
| Resistance | 9.390 | 14.05 | 11.65 |
| Spread/Res. | -12.57% | -41.57% | -29.53% |
| Spread/Supp. | +4.19% | +4.19% | +1.11% |
| Support | 7.880 | 7.880 | 8.120 |
- Stock Market
- Equities
- 301060 Stock
- Charts Shanghai Labway Clinical Laboratory Co., Ltd
